by Eric Christianson | Nov 13, 2024 | Respiratory Medication and Disease State Clinical Pearls
Two tests are commonly used in asthma assessments to monitor symptom control and airflow and this blog post will discuss their use and how they determine appropriate treatment options. Important tests pharmacists should know include the Asthma Control Test and a Peak...
by Eric Christianson | Nov 6, 2024 | Hematology and Immunology Medication and Disease State Clinical Pearls
Anemia is a blood disorder that has an impact on the red blood cells. Many different types of anemia can exist in patients. In this post, we are going to discuss pernicious anemia. What is Pernicious Anemia? Pernicious anemia is a very rare autoimmune disorder...
by Eric Christianson | Nov 3, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
There are two agents that are frequently used in alcohol use disorder. Acamprosate and naltrexone have distinct advantages and disadvantages in the treatment of alcohol use disorder. In this article, we will compare the clinical benefits and risks of acamprosate vs...
by Eric Christianson | Oct 30, 2024 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Dementia with Lewy Bodies (DLB) is a type of dementia grouped under the term “Lewy Body Dementia” along with Parkinson Disease with Dementia (PDD)1. The main symptoms of DLB are parkinsonism, REM sleep disorder, visual hallucinations, and changes in cognition2. There...
by Eric Christianson | Oct 23, 2024 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Peripheral neuropathy occurs when nerve fibers outside the brain and spinal cord are disrupted. Often, it is described as nerve pain throughout the limbs, most commonly in the hands and feet. Symptoms include numbness, tingling, pain, and loss of sensation. Today, we...
by Eric Christianson | Oct 16, 2024 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Pivmecillinam, also known as Pivya, is an oral antibiotic that was FDA-approved in April of 2024 for use against uncomplicated urinary tract infections (UTI) in female patients.1 Pivmecillinam Literature Pivmecillinam falls in the class of penicillin antibiotics. It...
